Feedback / Questions
izokibep (ABY-035) - Affibody, ACELYRIN
https://www.prnewswire.com/news-releases/acelyrin-inc-closes-250-million-series-b-financing-and-announces-licensing-of-izokibep-a-late-stage-il-17a-inhibitor-to-treat-inflammatory-diseases-301424582.html
Nov 16, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next